Ayash v. Dana Farber Cancer Institute

7 Mass. L. Rptr. 176
CourtMassachusetts Superior Court
DecidedJuly 15, 1997
DocketNo. 960565E
StatusPublished
Cited by3 cases

This text of 7 Mass. L. Rptr. 176 (Ayash v. Dana Farber Cancer Institute) is published on Counsel Stack Legal Research, covering Massachusetts Superior Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ayash v. Dana Farber Cancer Institute, 7 Mass. L. Rptr. 176 (Mass. Ct. App. 1997).

Opinion

Lauriat, J.

This motion for partial summary judgment, part of a case involving, inter alia, allegations of libel and invasion of privacy arising from intense publicity over medical errors that led to the death of a patient at a prestigious Boston hospital, raises difficult issues of media law: when is an event “newsworthy,” and when can this issue be decided by the court as a matter of law?

For the reasons that follow, the court concludes that the events reported in the media accounts at issue were indeed newsworthy as a matter of law. Accordingly, the court allows the motion of defendants The Boston Globe (“the Globe”) and Richard A. Knox (“Knox”) for summary judgment on the claim of plaintiff Doctor Lois Ayash (“Ayash”) for invasion of privacy (Count VII of the Complaint).

BACKGROUND

On December 3, 1994, Betsy Lehman (“Lehman”), a columnist for the Globe, died at the Dana Farber [177]*177Cancer Institute (“Dana Farber”). Lehman was a patient in an experimental breast cancer treatment protocol (“the protocol") for women whose cancers had not been responsive to more traditional forms of treatment. The protocol was designed to test on women the efficacy and safety of high doses of cyclophosphamide, a drug used in chemotherapy. The plaintiff in this action, a physician at Dana Farber, was Protocol Chair, which gave her responsibilities relating primarily to the research aspects, as opposed to the clinical management, of the protocol.

In February 1995, a data clerk at Dana Farber discovered that Lehman and another patient in the protocol had accidentally been given overdoses of cyclophosphamide in November 1994. Due to a physician’s error in interpreting protocol doses, the two patients were given four times the prescribed dose. Dana Farber officials, following this discovery, suspended the clinical privileges of two physicians who had been directly involved with the treatment of the two patients when the overdoses occurred. Both physicians were also placed on administrative duty. No action was taken then against Ayash, who did not have any direct clinical responsibilities for the patients at the time of the overdoses.1

On March 23, 1995, defendant Knox, a reporter for the Globe, published an article in that newspaper pertaining to the overdoses given to Lehman and the other patient. The article identified Ayash as both “the leader of the team” and a co-signatory of the order which led to the overdoses, and implied Ayash had been placed on administrative duty. As stated above, Ayash was not the clinical “leader” of the program; nor did she co-sign the overdose order. Another Knox article appeared on March 26, 1995. Additionally, Globe editorials were published which excoriated Dana Farber and its physicians for the overdoses.

On March 31, 1995, Dr. Ayash’s clinical privileges were suspended and she was assigned to administrative duty. Additionally, two internal Dana Farber investigations of her conduct began. On May 2, 1995, Knox published an article in the Globe stating that Ayash and another physician had been “singled out in an internal disciplinary process launched last month by Dana Farber.” On June 4, 1995, the Globe published a "correction,” stating that Ayash had been erroneously identified in the original Knox article as having countersigned the overdose order.

Another Knox article appeared on October 31, 1995, which discussed internal Dana Farber documents relating to the investigations of the overdoses. Although Dana Farber had publicly released some materials relating to the investigations, Knox’s article also stated that a non-public summary of an internal investigation had been “obtained by the Globe.” The article also stated that Ayash was under investigation by the Massachusetts Board of Registration in Medicine.

In August 1995, Ayash received an oral reprimand by the president of Dana Farber for her alleged failure to detect the overdoses earlier than the point at which they were discovered.

DISCUSSION

Summary judgment must be granted where there are no material facts in dispute and the moving party is entitled to judgment as a matter of law. Cassesso v. Commissioner of Correction, 390 Mass. 419, 422 (1983); Community National Bank v. Dawes, 369 Mass. 550, 553 (1976); Mass.R.Civ.P. 56(c). The moving party bears the burden of affirmatively demonstrating the absence of a triable issue, and that the moving party is entitled to judgment as a matter of law. Pederson v. Time, Inc., 404 Mass. 14, 16-17 (1989). With respect to any claim on which the party moving for summary judgment does not have the burden of proof at trial, it may demonstrate the absence of a triable issue either by submitting affirmative evidence that negates an essential element of the opponent’s case or “by demonstrating that proof of that element is unlikely to be forthcoming at trial.” Flesner v. Technical Communications Corp., 410 Mass. 805, 809 (1991); accord, Kourouvacilis v. General Motors Corp. 410 Mass. 706, 716 (1991). “If the moving pariy establishes the absence of a triable issue, the party opposing the motion must respond and allege specific facts which would establish the existence of a genuine issue of material fact in order to defeat a motion for summary judgment.” Pederson v. Time, Inc., 404 Mass. at 17. The opposing pariy cannot rest on his or her pleadings and mere assertions of disputed facts to defeat the motion for summary judgment. LaLonde v. Eissner, 405 Mass. 207, 209 (1989).

I.

The Globe has moved for summary judgment on Ayash’s invasion of privacy claim brought under G.L.c. 214, § IB (Count VII). The tort of invasion of privacy is of relatively recent vintage, and has been called “one of the most noteworthy legal inventions of the 20th Century." The Florida Star v. B.J.F., 491 U.S. 524, 550 (1989) (White, J. dissenting). The development of a legal action for public exposure of private, personal facts is traced to an article by Samuel D. Warren and Louis D. Brandeis, “The Right to Privacy,” 4 Harv.L.Rev. 193 (1890). Another landmark in the development of this tort came with the publication of Dean Prosser’s “Privacy," 4 Cal.L.Rev. 383 (1960), which discussed what are now recognized as the four types of invasion of privacy. See also Restatement of Torts 2d, §652A.2

Massachusetts has codified the right to privacy in G.L.c. 214, §1B, which creates a right “against unreasonable, substantial or serious interference” with a person’s privacy. Although the Supreme Judicial Court has never decided whether or not to recognize a common law invasion of privacy right, see Alberts v. Devine, 395 Mass. 59, cert. denied, 474 U.S. 1013 [178]*178(1985), c. 214, §1B is considered roughly analogous to the common law categoiy which proscribes public disclosure of private facts. Restatement of Torts 2d, §652A(2)(c); Bratt v. International Business Machines Corp., 392 Mass. 508, 519, n.15 (1984).

A.

In her brief, Ayash asserts that her claim belongs to the public disclosure species of invasion of privacy, which makes actionable disclosures of private, intimate facts about an individual that are not in any sense the business of the public or newsworthy. Doe v. Town of Plymouth, 825 F.Supp. 1102, 1109 (D.Mass. 1993) (disclosure of HIV status actionable).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Dineen v. Department of Social Services
11 Mass. L. Rptr. 184 (Massachusetts Superior Court, 2000)
Ayash v. Dana Farber Cancer Institute
8 Mass. L. Rptr. 216 (Massachusetts Superior Court, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
7 Mass. L. Rptr. 176, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ayash-v-dana-farber-cancer-institute-masssuperct-1997.